Table 1. Enhancement from DE-CESM in different histologic diagnoses.
| Histological Diagnosis | Enhanced (%) | Unenhanced (%) |
|---|---|---|
| Malignant (27) | ||
| IDC (8) | 8 (100) | 0 (0) |
| DCIS (19) | 16 (84.21) | 3 (15.79) |
| High Risk Lesions (32) | ||
| ADH (10) | 5 (50) | 5 (50) |
| FEA (22) | 1 (4.54) | 21 (95.46) |
| Benign Lesions (35) | ||
| Nonspecific Calcifications (8) | 1 (12.5) | 7 (87.5) |
| Adenosis (6) | 2 (33.33) | 4 (66.67) |
| Proliferative (5) | 0 (0) | 5 (100) |
| Non-Proliferative (5) | 0 (0) | 5 (100) |
| Nonspecific Hyperplasia (5) | 0 (0) | 5 (100) |
| Fibrocystic (3) | 0 (0) | 3 (100) |
| Fibroadenoma (3) | 0 (0) | 3 (100) |
Abbreviations: DE-CESM (dual-energy contrast enhanced subtracted mammography), IDC (invasive ductal carcinoma), DCIS (ductal carcinoma in situ), ADH (atypical ductal hyperplasia), FEA (flat epithelial atypia)